Stock Track | Twist Bioscience Plummets 5.97% Intraday After Reporting Wider-Than-Expected Quarterly Loss

Stock Track05-04

Twist Bioscience Corporation's stock plummeted 5.97% during intraday trading on Monday, following the release of its fiscal second-quarter 2026 financial results.

The significant drop came despite the company reporting quarterly sales of $110.7 million, which exceeded analyst estimates. Investors focused on the wider-than-anticipated net loss, which expanded to $44 million, or $0.71 per diluted share. This result missed the FactSet consensus estimate of a $0.50 loss per share. On an adjusted basis, the loss of $0.59 per share also fell short of the $(0.48) estimate.

While Twist Bioscience raised its full-year revenue outlook to a range of $442 million to $447 million, the substantial earnings miss appears to have driven negative sentiment, overshadowing the positive revenue guidance update.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1188834201?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-04 21:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188834201","market":"sg","top_or_hot":-1,"title":"Stock Track | Twist Bioscience Plummets 5.97% Intraday After Reporting Wider-Than-Expected Quarterly Loss","media":"Stock Track","content":"<p>Twist Bioscience Corporation's stock plummeted 5.97% during intraday trading on Monday, following the release of its fiscal second-quarter 2026 financial results.</p><p>The significant drop came despite the company reporting quarterly sales of $110.7 million, which exceeded analyst estimates. Investors focused on the wider-than-anticipated net loss, which expanded to $44 million, or $0.71 per diluted share. This result missed the FactSet consensus estimate of a $0.50 loss per share. On an adjusted basis, the loss of $0.59 per share also fell short of the $(0.48) estimate.</p><p>While Twist Bioscience raised its full-year revenue outlook to a range of $442 million to $447 million, the substantial earnings miss appears to have driven negative sentiment, overshadowing the positive revenue guidance update.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Twist Bioscience Plummets 5.97% Intraday After Reporting Wider-Than-Expected Quarterly Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Twist Bioscience Plummets 5.97% Intraday After Reporting Wider-Than-Expected Quarterly Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-04 21:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Twist Bioscience Corporation's stock plummeted 5.97% during intraday trading on Monday, following the release of its fiscal second-quarter 2026 financial results.</p><p>The significant drop came despite the company reporting quarterly sales of $110.7 million, which exceeded analyst estimates. Investors focused on the wider-than-anticipated net loss, which expanded to $44 million, or $0.71 per diluted share. This result missed the FactSet consensus estimate of a $0.50 loss per share. On an adjusted basis, the loss of $0.59 per share also fell short of the $(0.48) estimate.</p><p>While Twist Bioscience raised its full-year revenue outlook to a range of $442 million to $447 million, the substantial earnings miss appears to have driven negative sentiment, overshadowing the positive revenue guidance update.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1188834201","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188834201","pubTimestamp":1777901667,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Twist Bioscience Corporation's stock plummeted 5.97% during intraday trading on Monday, following the release of its fiscal second-quarter 2026 financial results.The significant drop came despite the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"个股追踪|Twist Bioscience公布季度亏损超预期后盘中暴跌5.97%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"Twist Bioscience Corporation's stock plummeted 5.97% during intraday trading on Monday, following the release of its fiscal second-quarter 2026 financial results.The significant drop came despite the company reporting quarterly sales of $110.7 million, which exceeded analyst estimates. Investors focused on the wider-than-anticipated net loss, which expanded to $44 million, or $0.71 per diluted share. This result missed the FactSet consensus estimate of a $0.50 loss per share. On an adjusted basis, the loss of $0.59 per share also fell short of the $(0.48) estimate.While Twist Bioscience raised its full-year revenue outlook to a range of $442 million to $447 million, the substantial earnings miss appears to have driven negative sentiment, overshadowing the positive revenue guidance update.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1188834201","isCrawlerRequest":true}